Project Grant R01HL168663
Award Date
7/16/24
Completion Date
4/30/28
Dollars Obligated
$2M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This $131,783 federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support research to identify blood and bronchoalveolar lavage fluid biomarkers for COPD phenotypes and acute exacerbations. The principal investigator, Dr. Craig Hersh at Brigham and Women's Hospital, will lead the development and implementation of a study protocol to collect biospecimens from COPD patients undergoing...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support research to identify functional genetic variants associated with chronic obstructive pulmonary disease (COPD) using deep learning models of alternative splicing in human airway epithelial cells. The total award amount is $2,377,618, with a project period from August 1, 2024 to May 31, 2028. The primary awardee,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $794,681 to Brigham & Women's Hospital Inc. to develop a population-based analytics and data infrastructure to evaluate the impact of non-COPD medications on COPD outcomes, leveraging claims data, electronic health records, and longitudinal COPD data. The award aims to identify drug repurposing opportunities for chronic...
This is a Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837). The $708,063 award will fund a research project at the University of Virginia from May 1, 2025 to February 28, 2030 to study post-transcriptional regulatory networks in chronic obstructive pulmonary disease (COPD). The key objectives are to: 1) develop methods to identify...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $798,062 Cooperative Agreement under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to The General Hospital Corporation (Massachusetts General Hospital) for the project "Mapping Airway Epithelial Cell-Immune Cell Interactions in Lung Health and Disease". The project aims to comprehensively define the signaling and spatial relationships between airway epithelial cells, airway structures, and...
This $753,018.00 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to identify early life risk factors that contribute to airway-to-lung mismatch, known as dysanapsis, which is a major predictor of chronic obstructive pulmonary disease (COPD) risk. The project will leverage 8 longitudinal birth cohorts to examine the relationships between early life exposures, such as...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, will support research on the role of the protein cofilin-1 in regulating mitochondrial function and cell repair mechanisms in the airway epithelium of patients with chronic bronchitis, a subtype of chronic obstructive pulmonary disease (COPD). The $762,867 award over a period of nearly 4 years will enable researchers at The Johns Hopkins University to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, aims to conduct a multi-omic characterization of chronic obstructive pulmonary disease (COPD) in females. The $572,076 award, granted to Pennsylvania State University's Milton S. Hershey Medical Center, will support research to better understand the genetic basis and molecular mechanisms underlying COPD in women, who are disproportionately...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $684,814 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the mechanisms by which tissue-resident lymphocytes suppress alveolar stem cells in emphysema, a subtype of chronic obstructive pulmonary disease (COPD). The research aims to uncover therapeutic approaches to attenuate the frequent...
This Project Grant award of $116,625 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a research study to characterize multi-volume airway and chest wall deformation in chronic obstructive pulmonary disease (COPD). The study will leverage established datasets from nationwide longitudinal lung studies to develop normative models of airway and chest wall deformation metrics, identify unique subtypes of...